Botulinum toxin A: A 9-month clinical and 3D in vivo profilometric crow's feet wrinkle formation study

Journal of Cosmetic and Laser Therapy

Volumn 6, Issue 1, 2004, Pages 16-20

  Levy, Jean Luc ^a   Servant, Jean Jacques ^b   Jouve, Elisabeth ^c  

^a Centre Laser Dermatologique   (France)

^b Eotech SA Marcoussis   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EYELID EDEMA; FEMALE; FOLLOW UP; HUMAN; IN VIVO STUDY; ORBICULARIS OCULI MUSCLE; PHOTOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF EVALUATION; SKIN MANIFESTATION; SKIN PROFILOMETRY; STATISTICAL ANALYSIS; THREE DIMENSIONAL IMAGING; WRINKLE;

ADULT; AGED; BOTULINUM TOXIN TYPE A; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; SKIN AGING;

EID: 2442670248     PISSN: 14764172     EISSN: None     Source Type: Journal    
DOI: 10.1080/14764170410028997     Document Type: Article

References (10)

1. Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 1992; 18: 17-21.
2. Keen M, Blitzer A, Binder W, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double blind, placebo-controlled study. Plast Reconstr Surg 1994; 94: 94-9.
3. Lowe NJ, Lask G, Yamauchi P, Moore D. Bilateral double blind randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J Am Acad Dermatol 2002; 47: 834-40.
4. Friedman PM, Skover GR, Payonk G, et al. 3D in vivo optical skin imaging for topographical quantitative assessment of non-ablative laser technology. Dermatol Surg 2002; 28: 199-204.
5. Friedman PM, Skover GR, Payonk G, Geronemus RG. Quantitative evaluation of nonablative laser technology. Semin Cutan Med Surg 2002; 21: 266-73.
6. Akazaki S, Nakagawa H, Kazama H, et al. Age-related changes in skin wrinkles assessed by a novel three-dimensional morphometric analysis. Br J Dermatol 2002; 147: 689-95.
7. Guerissi GO. Intraoperative injection of botulinum toxin A into orbicularis muscle for the treatment of crow's feet. Plast Reconstr Surg 2000; 105: 2219-25.
8. Flynn TJ, Carruthers A, Carruthers JA. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 2001; 27: 703-8.
9. Matarasso SL. Comparison of botulinum toxin types A and B: a bilateral and double blind randomized evaluation in the treatment of canthal rhytides. Dermatol Surg 2003; 29: 7-13.
10. Manaloto RM, Alster TS. Periorbital rejuvenation: a review of dermatologic treatment. Dermatol Surg 1999; 25: 1-9.